Potassium 5-Methyl-1,3,4-oxadiazole-2-carboxylate
- CAS No.888504-28-7
- GradeIndustrial / Pharmaceutical
- Availability● In Stock
High-purity Potassium 5-Methyl-1,3,4-oxadiazole-2-carboxylate (CAS 888504-28-7) designed for pharmaceutical synthesis. Ideal intermediate for Raltegravir production with strict quality control.
Request Bulk PricingProduct Technical Details
Product Overview
Potassium 5-Methyl-1,3,4-oxadiazole-2-carboxylate represents a critical heterocyclic building block within the modern pharmaceutical landscape. Identified by CAS number 888504-28-7, this specialized potassium salt is engineered for high-performance synthetic applications. Our manufacturing process ensures exceptional purity levels, making it an indispensable precursor for complex medicinal chemistry projects. The compound features a stable oxadiazole ring structure, which is highly valued for its metabolic stability and bioavailability enhancements in final drug formulations.
As a leading global manufacturer, we prioritize consistency and reliability. Every batch undergoes rigorous analytical testing to confirm identity and potency. This material is supplied as an off-white to light yellow crystalline powder, facilitating easy handling and dissolution in various synthetic routes. Our commitment to quality aligns with international pharmaceutical standards, ensuring that downstream processes remain efficient and compliant. The potassium counterion offers specific reactivity advantages in nucleophilic substitution reactions, streamlining the synthesis of complex API structures.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | Potassium 5-Methyl-1,3,4-oxadiazole-2-carboxylate |
| CAS Number | 888504-28-7 |
| Molecular Formula | C4H3KN2O3 |
| Molecular Weight | 166.176 g/mol |
| Appearance | Off-white to light yellow crystalline powder |
| Assay | ≥98.0% |
| Loss on Drying | ≤0.5% |
Industrial Applications
The primary application of this oxadiazole derivative lies in the synthesis of antiretroviral medications. Specifically, it serves as a key intermediate in the production of Raltegravir and Raltegravir potassium. These active pharmaceutical ingredients are essential components in HIV treatment regimens, highlighting the critical nature of this supply chain. The high purity of our intermediate ensures minimal impurity carryover, which is vital for meeting strict regulatory requirements in final drug product manufacturing.
Beyond its specific use in antiretroviral therapy, the 5-methyl-1,3,4-oxadiazole moiety is a versatile scaffold in medicinal chemistry. Researchers utilize this structure to explore new therapeutic avenues where metabolic stability is paramount. Our product supports both large-scale commercial production and research-scale development, providing flexibility for diverse client needs. The robust chemical stability of the oxadiazole ring allows for harsh reaction conditions during downstream processing without degradation.
Quality Assurance and Packaging
We understand that consistency is key in pharmaceutical manufacturing. Our facility operates under strict quality management systems to guarantee product integrity from synthesis to shipment. Each drum is sealed to prevent moisture ingress, preserving the chemical stability of the potassium salt during transit. We employ advanced chromatographic methods to verify assay levels and identify any trace impurities.
- Standard packaging includes 25 kg drums for industrial scalability.
- Custom packaging solutions are available upon customer request.
- Storage recommendations include cool, ventilated environments to maintain specification.
- Comprehensive documentation, including COA and MSDS, accompanies every shipment.
Partner with us for a reliable supply of high-quality pharmaceutical intermediates. Our technical team is ready to support your synthesis requirements with detailed specifications and logistical expertise. We maintain ample stock levels to ensure timely delivery for urgent production schedules.
